z-logo
open-access-imgOpen Access
The glutathione peroxidase 8 (GPX8)/IL-6/STAT3 axis is essential in maintaining an aggressive breast cancer phenotype
Author(s) -
Anees Khatib,
Balakrishnan Solaimuthu,
Michal Ben Yosef,
Areej Abu Rmaileh,
Mayur Tanna,
Gidi Oren,
Michal Schlesinger Frisch,
Jonathan H. Axelrod,
Michal Lichtenstein,
Yoav D. Shaul
Publication year - 2020
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2010275117
Subject(s) - phenotype , breast cancer , glutathione peroxidase , peroxidase , cancer research , glutathione , cancer , medicine , biology , immunology , enzyme , genetics , gene , biochemistry
Significance The cancer-dependent metabolic rewiring is mainly associated with the synthesis of building blocks that are needed to fulfill the proliferating cell metabolic requirements. However, the proliferation-independent instructive role of metabolic enzymes in tumor plasticity is still unclear. Here, we introduce glutathione peroxidase 8 (GPX8) as a metabolic enzyme that regulates cancer aggressiveness. We found that lack of GPX8 suppresses the aggressive phenotype and stemness features of the tumor cells. Mechanistically, these cells express a nonfunctional IL-6 receptor, which fails to interact with IL-6. This impaired binding hinders the activation of the downstream JAK/STAT3 signaling pathway, thereby inhibiting cancer cells transition to aggressive phenotypes. Thus, we present this GPX8/IL-6/STAT3 axis as a prototype of metabolic enzymes regulating cancer aggressiveness-associated signaling pathways.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom